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Burden of neonatal infection
Despite a substantial decline in childhood mortality rates in South 
Africa (SA)[1] and globally,[2] progress in neonatal mortality reduction 
has been much slower. Severe bacterial infections remain a leading 
cause of neonatal morbidity and mortality in sub-Saharan Africa, 
affecting nearly 1 million neonates and causing 250 000 deaths annu-
ally.[2] At the current rate of decline the United Nations Sustainable 
Development Goal of reducing neonatal mortality rates to ˂12 deaths 
per 1 000 live births by 2030, will not be attained by many African 
countries.[3] In SA, infections were estimated to cause 13.1% of 
neonatal deaths among babies >1 kg from 2012 to 2016 (Perinatal 
Problem Identification Programme (PPIP) data).[1] However, recent 
postmortem minimally invasive tissue sampling (MITS) data 
from the largest neonatal unit in SA (Chris Hani Baragwanath 
Academic Hospital, Johannesburg) demonstrate that hospital-
acquired, antimicrobial-resistant infections are now the leading 
cause of late neonatal mortality (after the first week of life). These 
hospital-acquired infections (HAIs) and infection-attributable deaths 
disproportionately affect preterm and low-birthweight neonates, 
and are responsible for 58% of deaths overall v. 70% of deaths 
in preterm infants.[4] Attributing cause of death with certainty, 
particularly in preterm infants, is difficult, and may lead to substantial 
underestimation of the true burden and impact of neonatal infection 
in SA. 
Challenges in diagnosis and 
surveillance of neonatal infection
Major challenges in diagnosing severe neonatal bacterial infections 
persist. These include the nonspecific clinical presentation of sepsis, 
inequitable access to microbiology laboratory services, high blood 
culture contamination rates and low pathogen yields from submitted 
specimens. Importantly, blood culture, the current gold standard for 
confirming bacteraemia, has a sensitivity of ~30%, much lower than 
molecular testing or postmortem MITS. The lack of validated clinical 
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definitions of neonatal sepsis further hampers efforts to quantify the 
neonatal infection burden. The World Health Organization (WHO) 
recommends using a combination of clinical signs to diagnose 
possible serious bacterial infection (pSBI), with a reported sensitivity 
of 85% and specificity of 75%.[5] However, even in the presence of 
these clinical signs, infection can still only be confirmed by blood 
culture. In Africa, there have been limited efforts to pool and 
harmonise existing laboratory data on neonatal infection, with not 
a single Anglophone country having population-level estimates of 
infection burden.[6] Despite the availability of better healthcare and 
information technology infrastructure, until recently no national 
surveillance programme existed for invasive neonatal infections, 
antimicrobial resistance among isolates and neonatal unit outbreaks 
of infection in SA. 
Measurement of infection-attributable 
mortality and morbidity
More accurate attribution of neonatal deaths to infection is key. 
Many infection-related preterm deaths are possibly ‘mislabelled’ as 
prematurity related, owing to a lack of accurate diagnostics.[4,7] Death 
notification forms, the basis of burden of disease and mortality 
studies, often indicate only the underlying cause rather than the 
immediate cause of death, resulting in underestimation of infection-
related deaths in preterm infants. Current SA neonatal mortality 
data[1] do not account for deaths in extremely-low-birthweight 
babies (<1 000 g) and babies who remain hospitalised in a neonatal 
unit beyond 28 days of life. Both these groups are at high risk 
of infection, and therefore should be included in neonatal unit 
surveillance activities as sentinel populations to serve as indicators 
of the impact of infection. Another important omission in current 
infection surveillance, is the failure to measure and report prolonged 
hospitalisation, repeated and prolonged antibiotic use, hospital costs, 
infection complications and lifelong neurodevelopmental disability 
related to neonatal infections.
Threat of hospital-acquired infection 
and antimicrobial resistance
PPIP cites HAIs as the second most prevalent avoidable factor in 
neonatal deaths.[1] Bloodstream infections are the most frequent 
HAI type in neonates, with infection rates varying from 4 to 14 cases 
per 1 000 patient-days, although data are available from only a 
few large institutions.[8-13] Similarly, neonatal infection outbreaks 
in SA are common, but are rarely reported. They are likely to be 
more frequent in units with overcrowding, understaffing, sharing 
of equipment and poor environmental cleaning.[14,15] The rise in 
antimicrobial resistance (AMR) among hospital pathogens globally 
is of concern for neonatal units, particularly those in Africa, where 
Gram-negative bacterial pathogens predominate.[8-12] 
Increases in AMR rates threaten the continued effectiveness of 
currently recommended first-line antibiotics, i.e. ampicillin/penicillin 
and gentamicin. Further, the epidemiology of neonatal sepsis 
seems to be changing, with AMR infections often occurring in the 
first days of life, possibly owing to vertical transmission following 
maternal AMR colonisation during antenatal care or labour and 
delivery. This necessitates early use of broad-spectrum, second-
line antibiotics, which further increases the risk of neonatal 
AMR bacterial colonisation and recurrent infections. Treatment 
options are limited for certain pathogens, e.g. carbapenem-resistant 
Acinetobacter baumannii (CRAB) and Enterobacteriaceae (CRE), 
which are the leading HAI pathogens in several SA neonatal 
units.[4,12] The true burden and impact of AMR in SA neonatal 
units remain largely unknown, because of a lack of national 
laboratory-based neonatal infection surveillance, limited detection 
and reporting of outbreaks and an absence of HAI surveillance 
programmes.
Factors contributing to hospital-
acquired infections and antimicrobial 
resistance
Hospitalised neonates are a vulnerable population owing to their 
immature immune systems, acquisition of multidrug-resistant (MDR) 
Gram-negative pathogens from their mothers at or after birth[16] 
and frequent pathogen exposure through contact with the hospital 
environment, equipment, staff, parents and other patients. Exposure 
events may lead to microbial colonisation only or to invasive 
infection, with consequent morbidity and mortality. Risk factors for 
neonatal HAI include low birth weight, prematurity, skin fragility, 
lack of breastfeeding, overcrowding, sharing of equipment and 
poor adherence to infection-prevention practices. Early exposure to 
broad-spectrum and prolonged antibiotic courses may permanently 
alter a neonate’s intestinal and skin microbiome and increase the risk 
of infection. Development of unit-specific antimicrobial treatment 
protocols based on local data, is considered critical to ensure 
appropriate empirical antibiotic use and to allow for de-escalation or 
discontinuation of antibiotics when indicated. 
The SA neonatal HAI incidence is likely to rise in the future for 
several reasons, including predicted population growth with rapid 
urbanisation, more hospital-based deliveries and immigration from 
neighbouring countries, exacerbating overcrowding and relative 
understaffing. Advances in neonatal care have led to ever-smaller 
babies surviving with prolonged hospital admissions, which confers 
at least twice the risk of HAI compared with term infants.[17] The 
rising demand for neonatal services is likely to outstrip the available 
space, equipment and the ability of public hospitals to maintain ageing 
infrastructure. Sharing of equipment, shortages of consumables, 
poor adherence to basic infection-prevention measures and lack of 
expertise in neonatal unit environmental and equipment cleaning 
are major challenges. Furthermore, insufficient specialist support 
and local leadership in infection prevention, hospital epidemiology, 
infectious diseases, microbiology and antimicrobial and diagnostic 
stewardships impede development and implementation of local 
guidelines, limit staff education opportunities and prevent the 
introduction of sustainable quality-improvement programmes.
The SA Neonatal Sepsis Task Force 
and other neonatal infection activities
The SA Neonatal Sepsis Task Force was launched at a special plenary 
session of the United SA Neonatal Association (USANA) conference 
in Port Elizabeth, SA, on 13 September 2019. Its primary role is to 
provide technical advice to the national and provincial departments 
of health and guidance to clinicians on surveillance for neonatal 
sepsis, prevention, identification and management of cases, and 
containment of outbreaks. The activities of the task force will focus 
particularly on prevention and management of AMR infections 
and/or neonatal HAIs, in public and private sector facilities. The task 
force is comprised of volunteer members co-opted from professional 
clinical societies, public hospitals and academia, with expertise in 
relevant disciplines, including neonatology, paediatric infectious 
diseases, clinical microbiology, antimicrobial stewardship, infection 
prevention and control, hospital epidemiology and AMR. The task 
force will co-ordinate and link activities to other organisations 
from which members will be drawn, including but not limited 
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to: the Federation of Infectious Diseases Societies of Southern 
Africa (FIDSSA), National Institute for Communicable Diseases 
(NICD), USANA, Neonatal Nursing Association of SA (NNASA), SA 
Paediatric Association (SAPA), National Health Laboratory Service 
(NHLS) and university-affiliated departments across the country. The 
task force will endeavour to establish and maintain communication 
channels with relevant departments and committees working with 
the National Department of Health (NDoH) (e.g. the Ministerial 
Advisory Committee on AMR, National Perinatal Mortality and 
Morbidity Committee (NaPeMMCo), Committee on Morbidity 
and Mortality in Children (CoMMic)) and provincial departments 
of health. 
Infection and outbreak surveillance 
Epidemiological data on all neonatal infections (maternally acquired 
or early onset v. hospital acquired, sporadic cases v. clusters/out -
breaks, bloodstream infections, meningitis and other infection types) 
are urgently needed from all SA units. This information will 
assist in developing national guidelines for the management of 
neonatal infections. It will also assist individual neonatal units 
and the NDoH to establish the burden of early-onset v. hospital-
acquired sepsis and the profile of AMR infections. Furthermore, 
the data will identify neonatal units with relatively higher infection 
rates and/or frequent outbreaks for the implementation of quality-
improvement interventions to reduce mortality and healthcare 
costs. Reported neonatal unit outbreaks in SA are limited,[14,15] 
although anecdotal reports from clinicians suggest that infection 
clusters and outbreaks occur frequently. Two externally funded 
research grants will contribute towards collection of data on neonatal 
bloodstream infections and outbreaks. Baby GERMS, a Bill and 
Melinda Gates Foundation-funded project of the NICD, will measure 
the national burden of neonatal sepsis in SA public sector hospitals 
and characterise infection risk factors, outcomes and AMR rates at 
6 regional neonatal units. The NeoAMR observational cohort is a 
Global Antibiotic Research and Development Partnership (GARDP)-
funded, multicountry study of neonatal sepsis patterns and impact, 
with 3 tertiary hospital sites participating in SA.[18]
Infection prevention
Infection prevention is the cornerstone of high-quality, safe 
provision of healthcare services to vulnerable populations such 
as hospitalised and preterm neonates. Despite the acknowledged 
importance of infection-prevention and control (IPC) programmes, 
many SA neonatal units lack the staff, infrastructure (water and 
isolation facilities) and consumables (e.g. alcohol hand-rub, gloves) 
to support effective IPC. National neonatal quality-improvement 
strategies include the promotion of breastfeeding, supported by the 
establishment of milk banks, clean cord care, strict adherence to basic 
hygiene in labour wards and nurseries, availability of appropriate 
antibiotic therapy and case management of neonatal sepsis, meningitis 
and pneumonia. Although these basic infection-prevention measures 
are important, specialised care and unit-specific infection-prevention 
protocols are needed where many unique procedures/practices 
occur, e.g. umbilical catheter placement, surfactant administration, 
incubator and radiant warmer care, preparation and storage of 
maternal and donor breast milk and kangaroo mother care. Audits 
of infection-prevention standards for neonatal units should take 
into consideration these unique practices, which pose particular 
infection-prevention challenges. Regular training of all staff, 
establishing an IPC-neonatal link nurse programme (to support 
IPC audits and staff training) and appointment of appropriately 
qualified IPC practitioners are needed for every neonatal unit 
countrywide. Similarly, efforts to improve IPC implementation and 
adherence in antenatal and intrapartum care are critical to prevent 
maternal colonisation and vertical transmission of antibiotic-resistant 
pathogens.[16] Implementation of the abovementioned processes and 
interventions should result in reduction in HAI rates and associated 
morbidity and mortality.
Antimicrobial stewardship
There is an urgent need for all hospitals to have antimicrobial 
stewardship programmes (ASPs) as one of the essential steps to 
conserve the efficacy of currently used antibiotics and delay progression 
of AMR. To develop strong and effective ASPs, neonatal units must 
first be assisted to quantify and track trends in their antimicrobial use. 
Institutional data on pathogen profile and AMR patterns are needed 
to construct locally appropriate treatment guidelines. Implementation 
of robust diagnostic and clinical guidelines, improved education of 
prescribers, feedback of antimicrobial consumption data and AMR 
trends, as well as strong leadership of the ASP team, are key to 
reducing inappropriate prescribing and the negative effects of antibiotic 
exposure in hospitalised neonates. More research is needed to develop 
and pilot a system for implementing and measuring the impact of ASPs 
in SA neonatal units. 
Conclusions
The burden of HAIs, AMR and infection outbreaks in SA neonatal 
units is likely to be higher than the currently available estimates, 
and may increase further. HAIs and outbreaks are often preventable 
through provision of high-quality basic neonatal care, appropriate 
antibiotic use and implementation of IPC best practices, integrated 
in antimicrobial and diagnostic stewardship programmes. Co- 
ordinated national surveillance of neonatal infections and audits of 
infection-prevention practices and antibiotic use will contribute to 
identification of high-infection-burden units and prioritise targeted 
interventions to reduce preventable harm to hospitalised neonates. 
Greater availability and dissemination of routine data will allow 
comparison between similar healthcare facilities and establish a 
baseline for measuring the impact of quality-improvement efforts. 
Even though the task to be undertaken is huge and includes many 
challenges, it is critical that this be done as an essential strategy to 
reduce the high neonatal mortality rate in SA. 
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